Blacklock's Reporter

Senators are questioning delays in Health Canada’s enactment of a drug safety bill passed in Parliament in 2014. The department earlier met with lobbyists to discuss a proposal to “reduce the burden” on drug companies: “Parliament passed this legislation without a dissenting vote.”